Capricor Therapeutics Inc (CAPR.OQ)
CAPR.OQ on NASDAQ Stock Exchange Capital Market
0.52USD
18 Apr 2019
0.52USD
18 Apr 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$0.52
$0.52
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
46,809
46,809
52-wk High
$1.57
$1.57
52-wk Low
$0.31
$0.31
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec '18 | 0.65 | -0.105 |
| Sep '18 | 0.22 | -0.135 | |
| Jun '18 | 0.40 | -0.142 | |
| Mar '18 | 0.40 | -0.136 | |
| FY 2017 | Dec '17 | 0.48 | 0.306 |
| Sep '17 | 0.31 | -0.117 | |
| Jun '17 | 1.00 | -0.157 | |
| Mar '17 | 0.88 | -0.171 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-19 | 2 | 0.65 | 1.30 | 0.00 | 2.80 |
| Year Ending Dec-20 | 2 | 0.65 | 1.30 | 0.00 | 2.80 |
| Earnings (per share) | |||||
| Year Ending Dec-19 | 2 | -0.34 | -0.19 | -0.50 | -0.43 |
| Year Ending Dec-20 | 2 | -0.41 | -0.29 | -0.52 | -0.48 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 109.48 | 62.40 | |
| P/E High - Last 5 Yrs. | 17.41 | 163.07 | 56.31 | |
| P/E Low - Last 5 Yrs. | 17.41 | 52.30 | 28.72 | |
| Beta | 1.53 | 1.16 | 0.93 | |
| Price to Sales (TTM) | 10.66 | 46.04 | 9.62 | |
| Price to Book (MRQ) | 3.60 | 13.22 | 4.53 | |
| Price to Tangible Book (MRQ) | 3.90 | 18.84 | 7.71 | |
| Price to Cash Flow (TTM) | -- | 73.00 | 43.23 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.09 | 1.54 | |
| Dividend Yield - 5 Year Avg | -- | 0.05 | 0.70 | |
| Dividend 5 Year Growth Rate | -- | 0.72 | 2.97 | |
| Payout Ratio(TTM) | -- | 8.42 | 21.72 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 36.21 | 23.35 | 9.20 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -37.32 | 67.54 | 8.35 | |
| Sales - 5 Yr. Growth Rate | 27.13 | 33.23 | 11.12 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -134.31 | -90.23 | 110.61 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -272.44 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 21.68 | 6.92 | |
| Capital Spending - 5 Yr. Growth Rate | 23.68 | 25.56 | 7.61 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.71 | 2.66 |
| Current Ratio (MRQ) | 6.75 | 3.55 | 3.63 |
| LT Debt to Equity (MRQ) | 73.15 | 7.07 | 13.26 |
| Total Debt to Equity (MRQ) | 73.15 | 20.06 | 16.97 |
| Interest Coverage (TTM) | -35.70 | 10.02 | 27.27 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 25.18 | 50.31 | |
| Gross Margin - 5 Yr. Avg. | -- | 59.97 | 50.77 | |
| EBITD Margin (TTM) | -907.61 | -- | -- | |
| EBITD - 5 Yr. Avg | -339.08 | -10.84 | 15.78 | |
| Operating Margin (TTM) | -917.04 | -109.08 | -2.09 | |
| Operating Margin - 5 Yr. Avg. | -266.31 | -26.44 | 11.11 | |
| Pre-Tax Margin (TTM) | -908.91 | -109.66 | -2.92 | |
| Pre-Tax Margin - 5 Yr. Avg. | -271.67 | -29.17 | 16.76 | |
| Net Profit Margin (TTM) | -908.91 | -116.04 | -6.86 | |
| Net Profit Margin - 5 Yr. Avg. | -271.67 | -34.35 | 11.72 | |
| Effective Tax Rate (TTM) | -- | 19.91 | 22.86 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.61 | 23.86 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 92,853 | 8,511,584 | 773,166,387 | |
| Net Income/Employee (TTM) | -843,950 | 1,995,061 | 89,056,262 | |
| Receivable Turnover (TTM) | 6.08 | 2.36 | 5.22 | |
| Inventory Turnover (TTM) | -- | 2.31 | 3.65 | |
| Asset Turnover (TTM) | 0.13 | 0.32 | 0.81 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -119.05 | 6.35 | 9.54 | |
| Return on Assets - 5 Yr. Avg. | -70.22 | 6.24 | 10.49 | |
| Return on Investment (TTM) | -134.46 | 7.96 | 11.78 | |
| Return on Investment - 5 Yr. Avg. | -99.16 | 8.16 | 13.39 | |
| Return on Equity (TTM) | -191.78 | 8.11 | 12.61 | |
| Return on Equity - 5 Yr. Avg. | -2,552.99 | 9.28 | 14.86 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -37.32 | -32.84 | 27.13 |
| EPS (TTM) % | -669.03 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Capricor Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -9.49 | -11.05 | 65 | 90 |
| 13 Week | -14.60 | -22.51 | 47 | 74 |
| 26 Week | -41.24 | -43.99 | 40 | 4 |
| 52 Week | -62.71 | -65.23 | 38 | 26 |
| YTD | 29.15 | 11.44 | 99 | 23 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 4.87% |
| # of Holders: | 21 |
| Total Shares Held: | 1,640,037 |
| 3 Mo. Net Change: | -20,922 |
| # New Positions: | 0 |
| # Closed Positions: | 1 |
| # Increased Positions: | 0 |
| # Reduced Positions: | 2 |
| # Net Buyers: | -2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.